Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Harnessing HIV for therapy, basic research and biotechnology.

Maciej Wiznerowicz1, Didier Trono

  • 1Frontiers in Genetics, National Center for Competence in Research, School of Life Sciences, Swiss Federal Institute of Technology, Laussane, Switzerland.

Trends in Biotechnology
|January 5, 2005
PubMed
Summary

Lentiviral vectors, particularly those derived from HIV, are powerful gene transfer tools for research and gene therapy. Their adaptability enables precise control over gene expression for applications like stem cell therapy and neuroscience.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tissue-specific restriction of transposon-derived regulatory elements safeguards cell-type identity.

Cell reports·2026
Same author

Identification of a lipid oxygen radical defense pathway and its epigenetic control.

Nature communications·2025
Same author

Mix-and-match between transposable elements and zinc finger proteins fuels genic and regulatory innovation.

Current opinion in genetics & development·2025
Same author

The 'mono-side' of cutaneous adverse drug reactions.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Cancer cells subvert the primate-specific KRAB zinc finger protein ZNF93 to control APOBEC3B.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Immunohistological Examination of HEATR1 and SLC27A2 Expression in ccRCC Samples to Evaluate Their Potential as Prognostic Markers-A Preliminary Study.

Cancers·2025

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Virology

Background:

  • Lentiviral vectors (lentivectors) have advanced gene transfer capabilities over the past decade.
  • HIV-based vectors are particularly promising for clinical applications.

Purpose of the Study:

  • To highlight the versatility and potential of lentiviral vectors in research and gene therapy.
  • To discuss the applications of HIV-based vectors in targeting hematopoietic stem cells and the central nervous system.

Main Methods:

  • Utilizing lentiviral vector technology for gene delivery.
  • Engineering vectors for precise control of transgene expression.
  • Application in delivering siRNAs, cDNA libraries, and creating transgenic animals.

Main Results:

Related Experiment Videos

  • Lentiviral vectors demonstrate potent and versatile gene transfer capabilities.
  • HIV-based vectors show promise for hematopoietic stem cell and CNS gene therapy.
  • Vector design allows for sophisticated control of transgene expression.

Conclusions:

  • Lentiviral vectors are invaluable tools for biological research and hold significant potential for gene therapy.
  • Recent applications expand their utility in addressing fundamental biological questions and developing novel therapeutics.